Hematopoietic Stem Cell Transplants May Provide Long-Term Benefit for People with MS Hematopoietic Stem Cell Transplants May Provide Long-Term Benefit for People with MS wpaadmin2021-01-20T15:40:00-06:00January 20th, 2021|Categories: Newswise|Tags: Alzheimer’s, Multiple Sclerosis, Parkinson's|
UCLA scientists develop method to more efficiently isolate and identify rare T cells UCLA scientists develop method to more efficiently isolate and identify rare T cells wpaadmin2021-01-11T16:26:43-06:00January 11th, 2021|Categories: Newswise|Tags: Breast Cancer, Covid-19, Diabetes, Heart, Multiple Sclerosis, Prostate Cancer|
Super-Ager Brains; No COVID-Guillain Barre Link; New IDEAS Launched Super-Ager Brains; No COVID-Guillain Barre Link; New IDEAS Launched wpaadmin2020-12-15T11:20:00-06:00December 15th, 2020|Categories: Therapy|Tags: ALS, Alzheimer’s, Covid-19, Multiple Sclerosis, Parkinson's|
Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of … Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of … wpaadmin2020-12-15T05:20:15-06:00December 15th, 2020|Categories: Therapy|Tags: ALS, Amyotrophic Lateral Sclerosis, Diabetes, Multiple Sclerosis|
FDA Approves Genentech's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and … FDA Approves Genentech's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and … wpaadmin2020-12-14T15:07:00-06:00December 14th, 2020|Categories: Therapy|Tags: Alzheimer’s, Breast Cancer, Heart, Liver failure, Multiple Sclerosis, Parkinson's|
FDA approves Roche's OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and … FDA approves Roche's OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and … wpaadmin2020-12-14T14:40:00-06:00December 14th, 2020|Categories: Therapy|Tags: Alzheimer’s, Diabetes, Multiple Sclerosis, Parkinson's|
Clinical Catch-Up: December 7-11 Clinical Catch-Up: December 7-11 wpaadmin2020-12-14T11:13:00-06:00December 14th, 2020|Categories: Therapy|Tags: ALS, Breast Cancer, Covid-19, CRISPR, Diabetes, Leukemia, Multiple Sclerosis|
Type 1 Diabetes Vaccine Candidate Launches USA Study Type 1 Diabetes Vaccine Candidate Launches USA Study wpaadmin2020-12-14T10:12:30-06:00December 14th, 2020|Categories: Therapy|Tags: Diabetes, Multiple Sclerosis|
MS News That Caught My Eye Last Week: Fatigue Trial, Pediatric MS Relapses, Stem Cell … MS News That Caught My Eye Last Week: Fatigue Trial, Pediatric MS Relapses, Stem Cell … wpaadmin2020-12-14T08:55:45-06:00December 14th, 2020|Categories: Therapy|Tags: Multiple Sclerosis|
Beneficial contribution of induced pluripotent stem cell-progeny to Connexin 47 dynamics during … Beneficial contribution of induced pluripotent stem cell-progeny to Connexin 47 dynamics during … wpaadmin2020-12-10T19:03:45-06:00December 10th, 2020|Categories: Therapy|Tags: Multiple Sclerosis|
